IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.298
-0.008 (-2.68%)
At close: Dec 5, 2025, 4:00 PM EST
0.300
+0.002 (0.70%)
After-hours: Dec 5, 2025, 8:00 PM EST
IGC Pharma Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for IGC Pharma stock have an average target of 4.00, with a low estimate of 3.50 and a high estimate of 4.50. The average target predicts an increase of 1,242.73% from the current stock price of 0.30.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 26, 2025.
Analyst Ratings
The average analyst rating for IGC Pharma stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4.25 → $4.5 | Strong Buy | Maintains | $4.25 → $4.5 | +1,410.57% | Aug 26, 2025 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +1,074.89% | Mar 6, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4 → $4.25 | Strong Buy | Maintains | $4 → $4.25 | +1,326.65% | Feb 24, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.75 → $4 | Strong Buy | Maintains | $3.75 → $4 | +1,242.73% | Dec 5, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.5 → $3.75 | Strong Buy | Maintains | $3.5 → $3.75 | +1,158.81% | Sep 3, 2024 |
Financial Forecast
Revenue This Year
1.32M
from 1.27M
Increased by 3.54%
Revenue Next Year
1.52M
from 1.32M
Increased by 15.12%
EPS This Year
-0.06
from -0.09
EPS Next Year
-0.07
from -0.06
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 1.4M | 1.6M |
| Avg | 1.3M | 1.5M |
| Low | 1.3M | 1.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 7.6% | 19.7% |
| Avg | 3.5% | 15.1% |
| Low | 0.5% | 11.7% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.06 | -0.07 |
| Avg | -0.06 | -0.07 |
| Low | -0.06 | -0.06 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.